Biological effect of different IMRT delivery techniques: SMLC, DMLC, and helical tomotherapy

Medical Physics

Volumn 37, Issue 2, 2010, Pages 762-770

  Shaikh, Mubin ^a   Burmeister, Jay ^a   Joiner, Michael ^a   Pandya, Shalini ^a   Zhao, Bo ^a   Liu, Qiang ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Biological effect; IMRT; Temporal pattern of dose accumulation; Tomotherapy; Treatment time

Indexed keywords

RADIOTHERAPY; TRANSMISSION CONTROL PROTOCOL; UROLOGY;

BIOLOGICAL EFFECTS; DOSE ACCUMULATION; IMRT; TOMOTHERAPY; TREATMENT TIME;

QUALITY CONTROL;

EID: 75749085851     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.3284369     Document Type: Article

References (23)

1. J. F. Fowler, J. S. Welsh, and S. P. Howard, " Loss of biological effect in prolonged fraction delivery.," Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 0360-3016 59, 242-249 (2004). 10.1016/j.ijrobp.2004.01.004
2. J. Z. Wang, X. A. Li, W. D. D'Souza, and R. D. Stewart, " Impact of prolonged fraction delivery times on tumor control: A note of caution for intensity-modulated radiation therapy (IMRT).," Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 0360-3016 57, 543-552 (2003). 10.1016/S0360-3016(03)00499-1 (Pubitemid 37040952)
3. W. F. Morgan, S. A. Naqvi, C. Yu, L. E. Smith, and M. Rose, " Does the time required to deliver IMRT reduce its biological effectiveness.," Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 0360-3016 54, 222 (2002). 10.1016/S0360-3016(02)03442-9
4. M. B. Altman, S. J. Chmura, J. O. Deasy, and J. C. Roeske, " Optimization of the temporal pattern of radiation: An IMRT based study.," Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 0360-3016 66, 898-905 (2006). 10.1016/j.ijrobp.2006.07.002
5. D. J. Brenner and E. J. Hall, " Conditions for the equivalence of continuous to pulsed low dose rate brachytherapy.," Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 0360-3016 20, 181-190 (1991).
6. M. Joiner and A. van der Kogel, Basic Clinical Radiobiology, 4th ed. (Hodder Arnold, Oxford University Press, USA, 2009).
7. L. R. Kelland and G. G. Steel, " Recovery from radiation damage in human squamous carcinoma of the cervix.," Int. J. Radiat. Biol. IJRBE7 0955-3022 55, 119-127 (1989). 10.1080/09553008914550121
8. G. Gordon Steel, J. M. Deacon, G. M. Duchesne, A. Horwich, L. R. Kelland, and J. H. Peacock, " The dose-rate effect in human tumour cells.," Radiother. Oncol. RAONDT 0167-8140 9, 299-310 (1987). 10.1016/S0167-8140(87) 80151-2
9. H. D. Thames, S. M. Bentzen, I. Turesson, M. Overgaard, and W. Van den Bogaert, " Time-dose factors in radiotherapy: A review of the human data.," Radiother. Oncol. RAONDT 0167-8140 19, 219-235 (1990). 10.1016/0167-8140(90)90149-Q
10. S. M. Bentzen and M. A. Ritter, " The alpha/beta ratio for prostate cancer: What is it, really?," Radiother. Oncol. RAONDT 0167-8140 76, 1-3 (2005). 10.1016/j.radonc.2005.06.009 (Pubitemid 41096507)
11. J. Z. Wang, M. Guerrero, and X. A. Li, " How low is the alpha/beta ratio for prostate cancer?," Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 0360-3016 55, 194-203 (2003). 10.1016/S0360-3016(02)03828-2 (Pubitemid 36020360)
12. S. G. Williams, J. M. Taylor, N. Liu, Y. Tra, G. M. Duchesne, L. L. Kestin, A. Martinez, G. R. Pratt, and H. Sandler, " Use of individual fraction size data from 3756 patients to directly determine the alpha/beta ratio of prostate cancer.," Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 0360-3016 68, 24-33 (2007). 10.1016/j.ijrobp.2006.12.036
13. S. P. Lee, M. Y. Leu, J. B. Smathers, W. H. McBride, R. G. Parker, and H. R. Withers, " Biologically effective dose distribution based on the linear quadratic model and its clinical relevance.," Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 0360-3016 33, 375-389 (1995). 10.1016/0360-3016(95)00162-R
14. B. Maciejewski, H. R. Withers, J. M. Taylor, and A. Hliniak, " Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: Tumor dose-response and repopulation.," Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 0360-3016 16, 831-843 (1989).
15. B. Maciejewski, H. R. Withers, J. M. Taylor, A. Zajonc-Slowakiewicz, and A. Mistur, " Radiotherapy of tonsillar cancer. II. Tumor repopulation and normal tissue tolerance.," Nowotwory ZZZZZZ 0029-540X 39, 99-110 (1989).
16. M. Rezvani, J. F. Fowler, J. W. Hopewell, and C. J. Alcock, " Sensitivity of human squamous cell carcinoma of the larynx to fractionated radiotherapy.," Br. J. Radiol. BJRAAP 0007-1285 66, 245-255 (1993). 10.1259/0007-1285-66-783-245
17. M. Stuschke and H. D. Thames, " Fractionation sensitivities and dose-control relations of head and neck carcinomas: Analysis of the randomized hyperfractionation trials.," Radiother. Oncol. RAONDT 0167-8140 51, 113-121 (1999). 10.1016/S0167-8140(99)00042-0 (Pubitemid 29320303)
18. G. A. Ezzell, J. Burmeister, N. Dogan, T. J. LoSasso, D. Mihailidis, A. Molineu, J. R. Palta, C. R. Ramsey, B. J. Salter, J. Shi, P. Xia, N. J. Yue, and Y. Xiao, " IMRT commissioning: Multiple institution planning and dosimetry comparisons. A Report from AAPM Task Group 119.," Med. Phys. MPHYA6 0094-2405 36, 5359-5373 (2009). 10.1118/1.3238104
19. NCI Protocol, " Phase I/II hypofractionated radiotherapy for prostate cancer.," Protocol ID R002803.
20. C. R. King, J. D. Brooks, H. Gill, T. Pawlicki, C. Cotrutz, and J. C. Presti, Jr., " Stereotactic body radiotherapy for localized prostate cancer: Interim results of a prospective phase II clinical trial.," Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 0360-3016 73, 1043-1048 (2009). 10.1016/j.ijrobp.2008.05.059
21. S. Levegrun, A. Jackson, M. J. Zelefsky, M. W. Skwarchuk, E. S. Venkatraman, W. Schlegel, Z. Fuks, S. A. Leibel, and C. C. Ling, " Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: Pitfalls in deducing radiobiologic parameters for tumors from clinical data.," Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 0360-3016 51, 1064-1080 (2001). 10.1016/S0360- 3016(01)01731-X (Pubitemid 33026439)
22. R. Tarnawski, J. Fowler, K. Skladowski, A. Swierniak, R. Suwinski, B. Maciejewski, and A. Wygoda, " How fast is repopulation of tumor cells during the treatment gap?," Int. J. Radiat. Oncol., Biol., Phys. IOBPD3 0360-3016 54, 229-236 (2002). 10.1016/S0360-3016(02)02936-X (Pubitemid 34899671)
23. W. F. Verbakel, S. Senan, F. J. Lagerwaard, J. P. Cuijpers, and B. J. Slotman, " Comments on Single-Arc IMRT?'.," Phys. Med. Biol. PHMBA7 0031-9155 54, L31-L34 (2009). 10.1088/0031-9155/54/8/L01